NFKB1 and thrombotic disease: IL-18 can alter NF-κB, causing damage, apoptosis, and other changes of the venous endothelial cells. The changes of endothelial cells cause anomalies in thrombotic disease-related cell function markers, vWF, P-selectin, and t-PA, resulting in thrombus formation (45).